BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29287594)

  • 21. Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment.
    Morikawa A; Li J; Ulintz P; Cheng X; Apfel A; Robinson D; Hopkins A; Kumar-Sinha C; Wu YM; Serhan H; Verbal K; Thomas D; Hayes DF; Chinnaiyan AM; Baladandayuthapani V; Heth J; Soellner MB; Merajver SD; Merrill N
    Cancer Res Commun; 2023 Jun; 3(6):1093-1103. PubMed ID: 37377606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.
    Wikman H; Westphal L; Schmid F; Pollari S; Kropidlowski J; Sielaff-Frimpong B; Glatzel M; Matschke J; Westphal M; Iljin K; Huhtala H; Terracciano L; Kallioniemi A; Sauter G; Müller V; Witzel I; Lamszus K; Kemming D; Pantel K
    Oncotarget; 2014 May; 5(10):3076-87. PubMed ID: 24833255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
    Varešlija D; Priedigkeit N; Fagan A; Purcell S; Cosgrove N; O'Halloran PJ; Ward E; Cocchiglia S; Hartmaier R; Castro CA; Zhu L; Tseng GC; Lucas PC; Puhalla SL; Brufsky AM; Hamilton RL; Mathew A; Leone JP; Basudan A; Hudson L; Dwyer R; Das S; O'Connor DP; Buckley PG; Farrell M; Hill ADK; Oesterreich S; Lee AV; Young LS
    J Natl Cancer Inst; 2019 Apr; 111(4):388-398. PubMed ID: 29961873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
    Park C; Yoon KA; Kim J; Park IH; Park SJ; Kim MK; Jang W; Cho SY; Park B; Kong SY; Lee ES
    Cancer Sci; 2019 May; 110(5):1760-1770. PubMed ID: 30811755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
    Tang D; Zhao X; Zhang L; Wang Z; Wang C
    J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genomic landscape of breast cancer brain metastases: a systematic review.
    Morgan AJ; Giannoudis A; Palmieri C
    Lancet Oncol; 2021 Jan; 22(1):e7-e17. PubMed ID: 33387511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
    Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
    Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival.
    Giannoudis A; Sartori A; Eastoe L; Zakaria R; Charlton C; Hickson N; Platt-Higgins A; Rudland PS; Irwin D; Jenkinson MD; Palmieri C
    Breast Cancer Res Treat; 2021 Nov; 190(2):241-253. PubMed ID: 34499316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
    Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
    Front Genet; 2022; 13():862264. PubMed ID: 35711946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
    Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
    BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
    Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
    Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
    Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
    BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
    Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
    J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Driver Genes and Interaction Networks Related to Brain Metastasis in Breast Cancer Patients.
    Zhang H; Wang X; Hou C; Yang Z
    Dis Markers; 2022; 2022():7631456. PubMed ID: 35132338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
    Kjällquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stålhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
    BMC Cancer; 2018 Feb; 18(1):174. PubMed ID: 29433456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
    Sambade MJ; Prince G; Deal AM; Trembath D; McKee M; Garrett A; Keith K; Ramirez J; Midkiff B; Blackwell K; Sammons S; Leone JP; Brufsky A; Morikawa A; Brogi E; Seidman A; Ewend M; Carey LA; Moschos SJ; Hamilton RL; Vincent B; Anders C
    Breast Cancer Res Treat; 2019 Jul; 176(2):321-328. PubMed ID: 31016641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays.
    Brogi E; Murphy CG; Johnson ML; Conlin AK; Hsu M; Patil S; Akram M; Nehhozina T; Jhaveri KL; Hudis CA; Seidman AD
    Ann Oncol; 2011 Dec; 22(12):2597-2603. PubMed ID: 21427063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and Immunological Characterization of Brain Metastases from Solid Cancers.
    Deguchi S; Akiyama Y; Mitsuya K; Ikeya T; Hozumi C; Iizuka A; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Ohshima K; Muramatsu K; Sugino T; Ohde Y; Tsubosa Y; Nishimura S; Yamaguchi K
    Anticancer Res; 2024 May; 44(5):1983-1994. PubMed ID: 38677762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
    Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
    Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.